digiMedical Solutions, Inc.(TM) Signs Contract With Orthopedic Surgeon, Dr. Howard Kapp, in Support of $10 Million 2008 Revenue Goal

Recent Contracts Increase Digital Prescription Reauthorization Call Volume by 200%


COLLEYVILLE, TX--(Marketwire - April 15, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has signed a contract with Dr. Howard Kapp in Naples, Florida, to implement the digiRX system and digiReauth call center services. digiRX and digiReauth, which are both proprietary, Microsoft-based applications developed by digiMedical, will provide digital prescription handling for his office and will take over the prescription reauthorization processing and refill management services. Dr. Kapp is an Orthopedic Surgeon with Anchor Health Centers (www.anchorhealthcenters.com). Dr. Kapp studied medicine at Case Western Reserve University and completed his residency at Harvard University.

digiMedical Prescription Handling Software and Pharmacies

digiMedical Solutions, a Microsoft Partner, with operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting and the Company owns and operates five pharmacies throughout Texas and Florida.

200% Prescription Reauthorization Call Volume Increase with Signing of Recent Contracts

This contract follows digiMedical's recent announcements of other contracts with Drs. Santos-Ocampo, Axline and Spilker of the Collier Heart Group, the Medical Director of Vanish Vein and Laser Center and Dr. Wey of the Neuroscience and Spine Associates in Naples, Florida, expanding the Company's regional footprint in support of the Company's $10 million 2008 revenue goal.

digiMedical has seen an immediate increase in call volume for prescription reauthorizations since adding these recent contracts. David Lee, digiMedical CEO, stated, "We are very pleased with the quick results we have seen from increasing our sales team in the Naples and Fort Meyers markets. Not only have we recently added several new doctors, we have also seen a significant increase in prescription reauthorizations with an over 200% call volume increase in our digiReauth center. Each new doctor can add hundreds of patients to our network who in turn drive our prescription sales and company revenue."

Bill Whitmore Joins Board of Advisors

Last week, digiMedical announced the appointment of Bill Whitmore to the Company's Board of Advisors. Mr. Whitmore will assist the Company in continuing to expand the sales team and sales strategies to support the Company's 2008 $10 million revenue goal. Mr. Whitmore has nearly 10 years of professional sales experience and is currently a Major Account Manager for Logix Communications Enterprises, Inc., a $105 million dollar, Houston-based telecommunications company.

Recent Analyst Report Coverage with Recommendation of $0.30 or Higher

Micros Report initiated research coverage of digiMedical Solutions and issued a report reviewing the Company's historical operations and 2008 business plan. As described in the report, digiMedical has created a new breed of pharmacy, integrating its own suite of proprietary software handling prescriptions digitally and securely from the physician's office into company owned brick and mortar pharmacies. According to the report, prescription drug sales and utilization are growing rapidly and the market is expected to grow 148% by 2016 to nearly $500 billion in sales.

Michael Willingham, Micros Report Director of Research, authored the report which includes a Fair Value Target price for DGMS of $0.30. This valuation is based on company characteristics that give it the potential to trade in a range as high as $0.89 vs. the recent close of $0.07. In the report, Mr. Willingham stated, "digiMedical's proprietary technology solution positions the company to profit from both the traditional existing pharmacy market space and the future of digital prescription fulfillment."

The report is available at http://www.digimedical.com/news/news.aspx under "Featured Presentation." Interested parties may also access the report by going to the www.MicrosReport.com homepage or by emailing ir@digimedical.com and requesting a copy.

Corporate Overview Now Available on Yahoo! Finance

A Corporate Overview Report on the Company is now available on Yahoo! Finance. The Report features digiMedical's proprietary, Microsoft-based digital prescription handling technology, brick and mortar pharmacy locations and recent Board of Directors expansion in preparation for a move to the OTCBB. The Company has grown from a start-up in 2005 to forecasting 2008 revenues of $10 million. The report also highlights the first analyst review on the company with a recommendation of $0.30 or higher.

To request a copy of the report, please go to http://finance.yahoo.com/q?s=dgms.pk and click "Download Annual Report" under the Company's stock chart.

Company Information and Updates

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to receive more information on the company, please send an e-mail to ir@digimedical.com.

About Anchor Health Centers (www.anchorhealthcenters.com)

With locations throughout Southwest Florida, Anchor Health Center's physicians are affiliated with two of the nation's top hospitals, Massachusetts General Hospital and Brigham & Women's Hospital. Anchor's physicians with experts in both specialty and primary care to ensure the finest medical care available.

About digiMedical Solutions, Inc. ™

digiMedical Solutions, Inc.™ (http://www.digimedical.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates five (5) pharmacies located in Texas and Florida. digiMedical Solutions'™ unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029